Investor profile
Flerie Invest has backed 6 European tech companies across 7 funding rounds between 2020 and 2023, joining rounds totalling €125M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Microbiotica | UK | 1 | €61M |
| EpiEndo Pharmaceuticals | Iceland | 1 | €20M |
| KAHR Medical | Israel | 1 | €17M |
| AnaCardio | Sweden | 1 | €14M |
| Synerkine Pharma | Netherlands |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Microbiotica | Series B | €61M | 2022-03 |
| EpiEndo Pharmaceuticals | Series A | €20M | 2021-08 |
| KAHR Medical | Series D+ | €17M | 2020-02 |
| AnaCardio |
| 2 |
| €8.8M |
| Amarna Therapeutics | Netherlands | 1 | €5.0M |
| Series A |
| €14M |
| 2022-09 |
| Synerkine Pharma | Series A | €5.3M | 2023-10 |
| Amarna Therapeutics | Other | €5.0M | 2021-12 |
| Synerkine Pharma | Series A | €3.5M | 2021-12 |
